Cardiovascular Actions of U50,488H and Related Kappa Agonists
- 1 June 1993
- journal article
- Published by Wiley in Cardiovascular Drug Reviews
- Vol. 11 (2) , 151-164
- https://doi.org/10.1111/j.1527-3466.1993.tb00273.x
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Inhibition of carbachol-stimulated phosphoinositide turnover by U-50,488H in rat hippocampus — involvement of GTP-binding proteinEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Vascular effects of some opioid receptor agonistsCanadian Journal of Physiology and Pharmacology, 1991
- 2-(3,4-Dichlorophenyl)-N-methyl-N-[2-(1-pyrrolidinyl)-1-substituted-ethyl]-acetamides: the use of conformational analysis in the development of a novel series of potent opioid .kappa. agonistsJournal of Medicinal Chemistry, 1991
- The k-opiate agonist U50488H decreases the entry of 45Ca into rat cortical synaptosomes by inhibiting N- but not L-type calcium channelsNeuropharmacology, 1990
- Kappa opioid receptors stimulate phosphoinositide turnover in rat brainLife Sciences, 1990
- Analgesic activity of spiradoline mesylate (U-62,066E), a kappa opioid agonist in miceLife Sciences, 1989
- Opiod receptor and signal transductionTrends in Pharmacological Sciences, 1988
- Antiarrhythmic action of naloxone: Direct, non-opiate effect on the rat heartLife Sciences, 1988
- Possible inhibition of Ca++ pump of rat erythrocyte ghosts by opioid K agonistsLife Sciences, 1983
- Properties of a selective kappa agonist, U-50,488HLife Sciences, 1982